A study protocol for the N-ICE trial: A randomised double-blind placebo-controlled study of the safety and efficacy of N-acetyl-cysteine (NAC) as a pharmacotherapy for methamphetamine (“ice”) dependence-Reference-Cited by-同舟云学术

A study protocol for the N-ICE trial: A randomised double-blind placebo-controlled study of the safety and efficacy of N-acetyl-cysteine (NAC) as a pharmacotherapy for methamphetamine (“ice”) dependence

Published:2019-06-04 Issue:1 Volume:20 Page:
ISSN:1745-6215
Container-title:Trials
language:en
Short-container-title:Trials

Author:

McKetin Rebecca^ORCID,Dean Olivia M.,Turner Alyna,Kelly Peter J.,Quinn Brendan,Lubman Dan I.,Dietze Paul,Carter Gregory,Higgs Peter,Baker Amanda L.,Sinclair Barbara,Reid David,Manning Victoria,te Pas Nina,Liang Wenbin,Thomas Tamsin,Bathish Ramez,Kent Margaret,Raftery Dayle,Arunogiri Shalini,Cordaro Frank,Hill Harry,Berk Michael

Funder

Australian National Health and Medical Research Council

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Medicine (miscellaneous)

Link

http://link.springer.com/content/pdf/10.1186/s13063-019-3450-0.pdf

Reference57 articles.

1. United Nations Office on Drugs and Crime. World Drug Report 2017. New York: United Nations; 2017. p. 13–20.

2. Degenhardt L, Baxter AJ, Lee YY, Hall W, Sara GE, Johns N, Flaxman A, Whiteford HA, Vos T. The global epidemiology and burden of psychostimulant dependence: findings from the Global Burden of Disease Study 2010. Drug Alcohol Depend. 2014;137:36–47.

3. Colfax G, Santos G-M, Chu P, Vittinghoff E, Pluddemann A, Kumar S, Hart C. Amphetamine-group substances and HIV. Lancet. 2010;376:458–74.